INS and myeloid sarcoma: In addition to their hypolipidaemic effects, hydroxycinnamates have also been shown to improve glucose homeostasis and insulin sensitivity, as observed in clinical studies with diabetic patients [36], healthy individuals [37] and subjects at risk of developing MS [38], among others.